Anno 2005 - Vol 13 - N° 3 - AIDA

53 ajnr-Leger D, Bague A, Lefebvre E, Cohen E, Chivor M. A possible role fòr squalene in rhe parhogenesis
of acne. II: In vivo srudy of squalene oxides in slcin surface and inrracomedonallipids of acne
parienrs. Br J Dermatol 1986; l 14:543-52.
54 Cordain L, Lindeberg S, Hurrado M, HiU K, Eaton SB, Brand-Miller J, Acne vulgaris: a disease of
We rern civilizarion. Arch Dermatol. 2002 Dee; 13 8(12): 1584-90.
55 Adebamowo CA, Spiegelman D , Danby FW, Frazier AL, WiUerr WC, Holmes MD. High school
dierary dairy inrake and reenage acne. J Am Acad Dermatol. 2005 Feb;52(2):207-14.
56 Levy RM, Huang EY, Roling D , Leyden J], Margolis DJ. Effect of anribiorics on rhe otopharyngeal
flora in parienrs wirh acne. Arch Dermatol. 2003 Apr; 13 9(4):467-7 I.
57 Ross JI, Snelling AM, Carnegie E, e colI. Anribiotic-resisrant acne: lessons from Europe. Br J
Dermatol. 2003 Mar; 148(3):467-78.
58 Leyden JJ. Effecr of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in
rhe reducrion of Propionibacrerium acnes. Curis. 2002 Jun-,69(6):475-80.
59 Skidmore R, Kovach R, Walker C e colI. Effecrs of subanrimicrobial-dose doxycycline in rhe rrearmenr
of moderare acne. Arch Dermatol. 2003 Apr;139(4):459-64.
60 Eady AE, Cove JH, Layron AM. Is anribiorie resistance in curaneous propionibacreria clinically relevanr?
implicarions of resisrance for acne parienrs and prescribers. Am J Clin Dermatol.
2003;4(12):813-3 l.
61 Dreno B. Topical anribacrerial rherapy for acne vulgaris. Drugs. 2004;64(21):2389-97.
62 Haider A, Shaw Je. Trearmenr of acne vulgaris.J AMA. 2004 Aug l 1;292(6):726-35.
63 Ozolins M , Eady EA, Avery AJ, e colI. Comparison of fìve antimicrobial regimens for rrearment of
mild to moderare infìammatory facial acne vulgaris in me communiry: randomised conrrolled rrial.
Lancer. 2004 Dee 18;364(9452):2188-95.
64 Ber had S, Kranjac Singer G , Parente JE, e collo Successful rrearmenr of acne vulgaris using a new
merhod: resulrs of a randomized vehicle- conrrolled trial of shorr-conract rherapy wirh O. l % razarorene
gel. Arch Derrnatol. 2002 Apr; 13 8(4):481-9.
65 Dreno B, Amblard P, Agache P, Siror S, Litoux P. Low dosis of zine gluconate for inflammatory acne.
Acra Derm Venereol 1989;69:541-543.
66 Dreno B, Bertoli V, OchsendorfF, Layron A, Mobacken H , DegreefH. European recommendarions
on rhe use of oral anribiotics for acne. Eur J Dermatol. 2004 Nov l ; 14(6):391-399.
67 rurkenboom MC, Meier GR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne
parienrs. Arch Inrern Med. 1999 Mar 8; 159(5):493-7.
68 Garner SE, Eady EA, Popescu C, Newton J, Li WA. Minocycline for acne vulgaris: effìcacy and
afery. Cochrane Darabase Sysr Rev. 2003;(1)
69 Ferahbas A, Uras S, Aykol D , Boriu M , Uksal U. Clinical evaluation of roximromycin: a doubleblfnd,
piacebo-controlled and crossover rrial in patients wirh acne vulgaris. J Dermatol. 2004
]an;31(1):6-9.
70 Par ad D, Pandhi R, Nagpal R, Negi KS. Azirhromycin monrhly pulse vs dajly doxycycline in rhe
rrearment of acne vulgaris. J Dermatol. 200 l Jan;28(1): 1-4.
71 Kus S, Yucelren D , Ayrug A. Comparison of effìcacy of azirhromycin vs. doxycycline in me trearmenr
of acne vulgaris. Cl in Exp Dermatol. 2005 May;30(3):215-20
72 Pelfìni e. Ogni donna con acne la sua "pillola". EBD. II n.3 dic.2004, 5-17
73 Pelfìni e., Regazzini R. Conrraccezione obbligatoria in dermatologia : quando e quale.
G. Iral. Dermatol. Venereol.. 1998;1334:187-97
74 Charalcida A. Mouser PE, Chu Ae. Safery and side effecrs of me acne drug, oral isorrerinoin. Experr
Opin Drug af 2004 Mar;3(2):119-29.
75 Goldsmirh LA, Bolognia JL, Callen JP, Chen SC, Feldman SR, Lim HW, e colI. American Academy
of Derrnatology Consensus Conferenee on rhe safe and optimal use of isorretinoin: summary and
recommendarions. J Am Acad Derrnatol. 2004 Jun;50(6):900-6.
6 Aliffrer N. Isorretinoine. JDP dico 2004
7 ClInliffe WJ Gollnick H PM. Acne diagnosi e terapia. Martin Dunirz Ed. Italiana. 200I.
78 Werr S. Idenrifìcarion and managemenr of oral isotretinoin use inconsisrent wirh producr labeling.
Manag Care Interface. 2003 Mar; 16(3):41-3,55.
79 ClIn liffe W], van de KerkhofPC, Caputo R, Cavicchini S, Cooper A, Fyrand aL e col I. Isotretinoin:
inrernarional survey. Dermatology 1997;194(4):351-7
.- CI)
C
CI)
C
u
«
Dermatologia
Ambulatoriale